In addition, Goldman Sachs has raised India back to an Overweight position, expecting a 14% upside with an end-2026 NIFTY ...

As of Monday, November 10, Mesa Laboratories, Inc.’s MLAB share price has surged by 5.38%, which has investors questioning if ...

Motilal Oswal recommended Neutral rating on Divis Laboratories with a target price of Rs 6925 in its research report dated November 08, 2025.

HOUSTON, Nov. 11, 2025 /PRNewswire/ — Salarius Pharmaceuticals, Inc. (“Salarius” or the “Company”) (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of ...

Get all the benefits of a deeply moisturizing, rich hand cream with the added power of encapsulated retinol with this Beauty ...

The U.S. Peptide Therapeutics Retail Market offers growth opportunities driven by increased healthcare spending and demand ...

If you buy something from this post, we may earn a small commission.

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

Aging plays a significant role in the disease onset and progression of multiple cerebrovascular events. Identification of the ...

The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...

Discover Codexis' Q3 2025 earnings highlights, strategic shift with Merck, and new leadership—positioning for growth in oligonucleotide manufacturing.

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...